PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Protected liver against CCl4-induced injuries and ethanol-induced hepatotoxicity, reducing ALT, AST, and ALP levels [PMID:32846588, PMID:29289796].
Improved metabolic and redox status in alloxan-induced diabetic rats [PMID:30622608] and prevented obesity, insulin resistance, and hepatic steatosis in high-fat diet mice [PMID:36297370].
Essential oil improved gastric ulcer healing in rats [PMID:33460758].
Demonstrated in vitro and in vivo efficacy against immature and adult worms of Schistosoma mansoni [PMID:24602876].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 30240600 (2018) — A review of biological and pharmacological activities of Baccharis trimera. · Chemico-biological interactions
- 2.PMID: 32846588 (2020) — Chemical characterization of polysaccharides from Baccharis trimera (Less.) DC. infusion and its hepatoprotective effects. · Food research international (Ottawa, Ont.)
- 3.PMID: 26236426 (2015) — Carqueja (Baccharis trimera) Protects against Oxidative Stress and β-Amyloid-Induced Toxicity in Caenorhabditis elegans. · Oxidative medicine and cellular longevity
- 4.PMID: 29289796 (2018) — Baccharis trimera protects against ethanol induced hepatotoxicity in vitro and in vivo. · Journal of ethnopharmacology
- 5.PMID: 20430095 (2010)